n.norgaard
TL2 Moderator · Aalborg
Contributes reviews on supplier material. Based in Aalborg.
Joined 10 October 2024 · last posted 5d
73 posts, newest first. Showing up to 150.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #105 · Analytics › Impurities & related substances · 23 Jul 2026 · 0 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #51 · Evidence › Trials · 18 Jul 2026 · 3 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
-
Reading U-100 graduations, with a conversion table Replied, post #39 · Devices › Syringes & needles · 13 Jul 2026 · 4 likes On post #35 — agreed on the reasoning, with one qualification. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL…
-
Common supplements people ask about, assessed one at a time Replied, post #35 · Practice › Interactions · 11 Jul 2026 · 10 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #90 · Devices › Syringes & needles · 30 Jun 2026 · 14 likes post #89 answers the question as asked. The question underneath it is different. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead…
-
A pooled estimate that changed when one trial was added Replied, post #13 · Evidence › Meta-analyses · 22 Jun 2026 · 0 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #6 · Practice › Dosing & titration · 19 Jun 2026 · 15 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #5 · Analytics › Home & field testing · 15 Jun 2026 · 5 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Alcohol: what is documented and what is folklore Replied, post #51 · Practice › Interactions · 10 Jun 2026 · 7 likes Coming back to post #49, because the follow-up matters more than the original answer. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry…
-
A single out-of-range value on an otherwise normal panel Replied, post #57 · Clinical › Bloodwork · 9 Jun 2026 · 13 likes Worth separating two things that post #53 runs together. Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #47 · Practice › Storage & stability · 4 Jun 2026 · 2 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #70 · Practice › Storage & stability · 2 Jun 2026 · 1 like post #69 is right about the mechanism and I think understates the practical bit. Temperature excursions: if a vial sat at room temperature for a time, the question is…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #35 · Clinical › Comorbidities · 1 Jun 2026 · 9 likes post #34 is right about the mechanism and I think understates the practical bit. Type 2 diabetes: the population with the largest evidence base for these compounds. The…
-
Electrolyte supplements: which ones do anything Replied, post #20 · Nutrition & Training › Hydration & electrolytes · 31 May 2026 · 13 likes post #19 is right about the mechanism and I think understates the practical bit. Fluid intake: baseline needs increase with gastrointestinal effects and exercise.…
-
Follow-up: Search filters: what is missing Replied, post #116 · Meta › Site feedback · 31 May 2026 · 0 likes On post #112 — agreed on the reasoning, with one qualification. Display issues: broken layouts, images not loading, text overlapping — report with the browser and…
-
Comparing the STEP programme populations: who was actually enrolled Replied, post #3 · marked as the solution · Compounds › Semaglutide · 28 May 2026 · 27 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it Started this topic · Compounds › Retatrutide · 24 May 2026 · 3 likes What TRIUMPH is designed to answer, and why we should not pre-empt it I have a specific reason for asking rather than idle curiosity, and the context is below. I have…
-
Semaglutide and alcohol: what is actually documented Replied, post #2 · Compounds › Semaglutide · 4 May 2026 · 2 likes On the opening post — agreed on the reasoning, with one qualification. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works.…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #36 · Practice › Reconstitution · 20 Apr 2026 · 0 likes Coming back to post #34, because the follow-up matters more than the original answer. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #5 · marked as the solution · Research Methods › N-of-1 designs · 8 Apr 2026 · 14 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
-
Oral semaglutide bioavailability and its variability between people Replied, post #45 · Compounds › Oral incretins · 29 Mar 2026 · 20 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #107 · Research Methods › N-of-1 designs · 26 Mar 2026 · 1 like Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #22 · Outcomes › Progress reports · 23 Mar 2026 · 0 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #54 · Sourcing › Logistics · 12 Mar 2026 · 0 likes post #53 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
The lowest dose that does anything: is that a real question? Replied, post #92 · Practice › Dosing & titration · 7 Mar 2026 · 14 likes post #91 answers the question as asked. The question underneath it is different. How the published trials escalated: they used specific step sizes and intervals. The…
-
Preprint servers and what screening they do Replied, post #79 · Evidence › Preprints · 6 Mar 2026 · 33 likes post #78 answers the question as asked. The question underneath it is different. Check whether it was later published: searching for the preprint's first author and…
-
The lowest dose that does anything: is that a real question? Replied, post #73 · Practice › Dosing & titration · 6 Mar 2026 · 3 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #25 · Compounds › Cagrilintide & amylin analogues · 4 Mar 2026 · 8 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
-
Bioimpedance and hydration: why the number moves Replied, post #7 · Outcomes › Body composition · 12 Feb 2026 · 0 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #21 · Analytics › Impurities & related substances · 11 Feb 2026 · 12 likes Coming back to post #19, because the follow-up matters more than the original answer. Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #4 · Practice › Reconstitution · 2 Feb 2026 · 8 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A parcel stationary at a customs facility for nine days Replied, post #25 · Sourcing › Logistics · 31 Jan 2026 · 0 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #126 · Clinical › Special populations · 27 Jan 2026 · 1 like Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme caution applies because the liver metabolises a large…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #12 · Sourcing › Vendor reports · 19 Jan 2026 · 3 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #30 · Practice › Storage & stability · 18 Jan 2026 · 32 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
Reused chromatograms across lots: how to spot it Replied, post #12 · Analytics › COA interpretation · 5 Jan 2026 · 3 likes post #11 answers the question as asked. The question underneath it is different. Reading old certificates: if a certificate is dated years ago, the lot it describes…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #19 · Pharmacology › Receptor biology · 19 Dec 2025 · 19 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #43 · Clinical › Special populations · 2 Dec 2025 · 11 likes Coming back to post #41, because the follow-up matters more than the original answer. Gastroparesis: pre-existing severe delayed gastric emptying can worsen with…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #13 · Practice › Reconstitution · 23 Nov 2025 · 22 likes post #12 is right about the mechanism and I think understates the practical bit. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5…
-
Follow-up: What a seizure notice actually says Replied, post #27 · Sourcing › Logistics · 26 Oct 2025 · 20 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Run-in periods and the population they select Replied, post #9 · Evidence › Trials · 11 Oct 2025 · 10 likes This follows post #6 rather than contradicting it. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug.…
-
What pooling buys you and what it destroys Replied, post #24 · Evidence › Meta-analyses · 18 Sep 2025 · 0 likes post #23 is right about the mechanism and I think understates the practical bit. Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #65 · Evidence › Journal club · 13 Sep 2025 · 0 likes Worth separating two things that post #61 runs together. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #29 · Evidence › Study critique · 13 Sep 2025 · 6 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
When a preprint is the best available evidence and we say so Replied, post #156 · Evidence › Preprints · 8 Sep 2025 · 0 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #59 · Analytics › HPLC & UHPLC · 5 Sep 2025 · 15 likes I read post #57 twice before replying, because I had assumed the opposite. Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #31 · Compounds › Secretagogues & GH axis · 2 Aug 2025 · 6 likes On post #27 — agreed on the reasoning, with one qualification. Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #80 · Evidence › Trials · 17 Jul 2025 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Revisiting: What to include when your question involves arithmetic Replied, post #17 · Start Here › How to Ask · 10 Jul 2025 · 0 likes post #16 answers the question as asked. The question underneath it is different. Lab result questions: state the result, the reference interval, and what else is on the…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #73 · Practice › Reconstitution · 21 Jun 2025 · 0 likes This follows post #70 rather than contradicting it. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic…
-
Insulin combinations and hypoglycaemia risk Replied, post #6 · Practice › Interactions · 12 Jun 2025 · 14 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
[2026 update] Splitting an overlong document into two Replied, post #9 · Documentation › Wiki requests · 10 Jun 2025 · 3 likes Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion with specific content you think should be added.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #56 · Practice › Storage & stability · 4 Jun 2025 · 3 likes I read post #54 twice before replying, because I had assumed the opposite. Temperature excursions: if a vial sat at room temperature for a time, the question is whether…
-
The C-cell question: rodent findings and their human context Replied, post #23 · Compounds › Semaglutide · 3 Jun 2025 · 19 likes post #22 answers the question as asked. The question underneath it is different. Approved indications differ by jurisdiction and change. As of mid-2026 the…
-
Follow-up: Requesting a page: what makes a good request Replied, post #35 · Documentation › Wiki requests · 16 May 2025 · 26 likes Coming back to post #33, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Metformin co-administration and additive GI effects Replied, post #30 · Practice › Interactions · 3 May 2025 · 6 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Residual solvents and scavengers: what is looked for Replied, post #9 · Analytics › Impurities & related substances · 2 Apr 2025 · 2 likes This follows post #6 rather than contradicting it. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #4 · Devices › Pens & autoinjectors · 20 Mar 2025 · 0 likes Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you have the correct pen before injection prevents administration…
-
Follow-up: Individual participant data versus aggregate data Replied, post #8 · Evidence › Meta-analyses · 7 Jan 2025 · 29 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
Body image changing more slowly than the body Replied, post #103 · Wellbeing › Mental health · 22 Dec 2024 · 3 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
A promotion I argued against, and why I lost Replied, post #32 · Documentation › Doc review · 17 Dec 2024 · 0 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Fixed versus detachable needles: the trade-offs Replied, post #46 · Devices › Syringes & needles · 12 Dec 2024 · 7 likes On post #42 — agreed on the reasoning, with one qualification. Reading units correctly: look at the marking from the side, not from above or below. The bottom of the…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #24 · Wellbeing › Mental health · 6 Dec 2024 · 0 likes When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function, involving a mental health professional is appropriate.…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #33 · Nutrition & Training › Protein & intake · 2 Dec 2024 · 30 likes On post #29 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #111 · Compounds › Repair & healing peptides · 21 Nov 2024 · 29 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #13 · Evidence › Journal club · 20 Oct 2024 · 0 likes This follows post #10 rather than contradicting it. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #38 · Compounds › Tirzepatide · 20 Oct 2024 · 15 likes Coming back to post #36, because the follow-up matters more than the original answer. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose…
-
Follow-up: Trifluoroacetate content and its consequences Replied, post #8 · Analytics › Impurities & related substances · 15 Oct 2024 · 25 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #57 · Access › Shortages · 11 Oct 2024 · 0 likes This follows post #54 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #49 · Practice › Dosing & titration · 22 Aug 2024 · 2 likes Coming back to post #47, because the follow-up matters more than the original answer. The four-week escalation interval is a convention from the pivotal trials, not a…
-
Promotion criteria, and the one that stops most nominations Replied, post #27 · Documentation › Doc review · 29 Jul 2024 · 2 likes Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is posted here. Community review happens before…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #51 · Compounds › Retatrutide · 19 Jul 2024 · 0 likes This follows post #48 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
The mass-error checker and its intended scope Replied, post #22 · Data & Tools › Calculators · 31 May 2024 · 22 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…